Residency · Residency · Psychiatry

Neuroleptic Malignant Syndrome and Serotonin Syndrome

Start here

Alright, intern. Look, I know you're running on fumes, but this is critical. Imagine you’re on call, and you get that dreaded page at 3 AM: "Patient's unresponsive, febrile, and stiff as a board." Your brain immediately snaps to two terrifying possibilities: Neuroleptic Malignant Syndrome (NMS) or Serotonin Syndrome (SS). Both are life-threatening, drug-induced nightmares that can spiral out of control in hours if you don't act fast. The trick is telling them apart quickly, because while some symptoms overlap, the underlying problem and the solution are distinctly different.

NMS usually follows initiation of a dopamine-blocking agent, often an antipsychotic, and presents with extreme muscle rigidity (think "lead pipe"), a sky-high fever (hyperthermia), changes in mental status, and a wildly unstable autonomic nervous system (heart rate, blood pressure all over the place). Think of it as a catastrophic shutdown of the body's internal thermostat and movement control. In contrast, Serotonin Syndrome is all about too much serotonin activity, typically from a combination of drugs, and it manifests with hyperactive reflexes, muscle clonus (like involuntary rhythmic jerking), agitation, and usually a less severe fever.

Your immediate job, regardless of which one you suspect, is to stop the offending medication. No questions asked. Then, you're going to support the patient: aggressive cooling for the fever, IV fluids, and benzodiazepines to calm agitation and muscle overactivity. But here’s the kicker for differentiation: if you see that extreme rigidity and a massive creatine kinase elevation, think NMS and consider specific treatments like dantrolene. If it's clonus and hyperreflexia, think Serotonin Syndrome and consider cyproheptadine. Get comfortable with these distinctions now, because when that page comes, you won't have time to second-guess.

Introduction

Neuroleptic malignant syndrome (NMS) and serotonin syndrome (SS) are life-threatening, drug-induced emergencies encountered in psychiatric practice. Both require rapid recognition and intervention. Despite overlapping features such as hyperthermia and altered mental status, these syndromes have distinct pathophysiologies, clinical presentations, and management strategies.

Neuroleptic Malignant Syndrome

Pathophysiology

Central dopamine D2 receptor blockade in the hypothalamus and basal ganglia. Results in thermoregulatory failure and extrapyramidal rigidity. Most commonly triggered by first-generation antipsychotics but can occur with any dopamine antagonist, including antiemetics (metoclopramide)

Clinical Features — The Classic Tetrad

Hyperthermia (temperature often > 40 C) Lead-pipe muscular rigidity. Altered mental status ranging from agitation to coma. Autonomic instability: labile blood pressure, tachycardia, diaphoresis.

Laboratory Findings

Markedly elevated creatine kinase (CK), often > 1000 IU/L. Leukocytosis, metabolic acidosis, elevated liver transaminases. Myoglobinuria raising the risk of acute renal failure.

Management

Immediate discontinuation of the offending agent. Aggressive IV hydration and cooling measures. Dantrolene (skeletal muscle relaxant) for severe rigidity. Bromocriptine or amantadine to restore dopaminergic tone. ICU admission for hemodynamic monitoring.

Serotonin Syndrome

Pathophysiology

Excess serotonergic activity at 5-HT1A and 5-HT2A receptors. Typically precipitated by drug combinations: SSRIs + MAOIs, SSRIs + tramadol, SSRIs + linezolid. Can also occur with single-agent overdose.

Clinical Features — Hunter Criteria

Clonus (spontaneous, inducible, or ocular) is the hallmark. Agitation, diaphoresis, diarrhea. Tremor and hyperreflexia. Hyperthermia (usually milder than NMS unless severe)

Differentiating NMS from Serotonin Syndrome

Management

Discontinue all serotonergic agents. Benzodiazepines for agitation and mild cases. Cyproheptadine (5-HT2A antagonist) for moderate to severe cases. Active cooling and supportive care. Avoid physical restraints that worsen hyperthermia and rhabdomyolysis.

Prevention Strategies

Perform thorough medication reconciliation before prescribing serotonergic agents. Allow adequate washout periods when switching antidepressants (especially MAOIs: 14 days) Educate patients about over-the-counter serotonergic substances (dextromethorphan, St. John's Wort) Monitor for early signs during antipsychotic initiation or dose escalation.

Key Clinical Pearls

NMS is a diagnosis of exclusion; always rule out infection, heatstroke, and malignant hyperthermia. Serotonin syndrome typically resolves within 24 hours of drug discontinuation if recognized early. Both syndromes can be fatal if untreated; mortality for NMS ranges from 5-20%. Rechallenge with antipsychotics after NMS is possible but requires a low-potency agent, low starting dose, and careful monitoring after a minimum 2-week drug-free interval. Clonus is the single most reliable distinguishing feature favoring serotonin syndrome over NMS.

References

1. Ware MR, Feller DB, Hall KL. Neuroleptic malignant syndrome: diagnosis and management. Prim Care Companion CNS Disord. 2018;20(1):17r02185.
2. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.
3. Dunkley EJC, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635-642.
4. Pileggi DJ, Cook AM. Neuroleptic malignant syndrome. Ann Pharmacother. 2016;50(11):973-981.

For the intern

When paged at 3am about fever and confusion in a patient on psychotropics, act immediately. Check vital signs, particularly temperature, and perform a focused neurological exam looking for rigidity versus clonus and hyperreflexia. Draw stat labs including creatine kinase (CK), complete blood count, comprehensive metabolic panel, and venous blood gas. Stop all suspected culprit medications immediately—this is the single most important intervention. Start aggressive IV fluid resuscitation (watching for myoglobinuria), initiate cooling measures if hyperthermic, and give benzodiazepines for agitation. Call your senior resident and consider ICU transfer. Do not wait until morning to act—both neuroleptic malignant syndrome (NMS) and serotonin syndrome can progress rapidly to multi-organ failure. Review the medication administration record thoroughly to identify recent antipsychotic or serotonergic drug changes.

Common pitfalls

• Mistaking NMS for infection: Fever and altered mental status trigger a sepsis workup, but the combination of hyperthermia with lead-pipe rigidity should immediately raise suspicion for NMS. Don't wait for cultures to discontinue antipsychotics.

• Missing polypharmacy in serotonin syndrome: Remember that linezolid, tramadol, ondansetron, and dextromethorphan have serotonergic properties. Check over-the-counter medications and recent antibiotic changes.

• Physical restraints in either syndrome: Restraining agitated patients increases muscle activity, worsening hyperthermia and rhabdomyolysis. Use chemical sedation with benzodiazepines instead.

• Continuing the offending agent: Some teams hesitate to stop antipsychotics in acutely psychotic patients, but untreated NMS carries 5-20% mortality. Psychiatric symptoms can be addressed after medical stabilization.

Make it stick

You're on your first night float and get a page: a patient admitted for psychosis, started on a new antipsychotic yesterday, is now febrile (104°F!), rigid, and barely responsive. Your heart sinks; you remember the lecture. Is this NMS? You rush to the room, instantly noting the "lead-pipe" stiffness and profuse sweating. You immediately order stat labs, including a CK which comes back sky-high. You discontinue the antipsychotic, start aggressive cooling, and call the ICU for transfer. The attending praises your rapid action: "You just saved this patient's kidneys, and potentially their life."

If you remember one thing

Neuroleptic malignant syndrome (NMS) presents with fever, rigidity, altered mental status, and autonomic instability, often with markedly elevated creatine kinase. Serotonin syndrome (SS) presents with clonus, hyperreflexia, agitation, and usually less severe hyperthermia.

Read this lecture as Markdown